Verition Fund Management LLC Acadia Pharmaceuticals Inc Transaction History

Verition Fund Management LLC

$23.6 Billion
Q4 2024

A detailed history of Verition Fund Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 82,622 shares of ACAD stock, worth $1.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

82,622

Holding current value

$1.63 Million

% of portfolio

0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$14.29 - $18.76 $1.18 Million - $1.55 Million	82,622 New	82,622 $1.52 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $275,279 - $346,830	18,829 New	18,829 $305,000
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $274,600 - $395,702	15,427 New	15,427 $369,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $153,426 - $321,005	11,793 New	11,793 $166,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $168,504 - $271,875	-10,036 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $158,368 - $248,591	10,036 New	10,036 $167,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $246,075 - $340,512	-5,996 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $1.13 Million - $1.77 Million	-31,121 Reduced 83.85%	5,996 $247,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $1.46 Million - $1.96 Million	37,117 New	37,117 $1.8 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $1.29 Million - $1.9 Million	-40,605 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $956,125 - $1.36 Million	26,405 Added 185.95%	40,605 $1.74 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $1.05 Million - $2.08 Million	-47,174 Reduced 76.86%	14,200 $511,000
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $1.43 Million - $1.73 Million	61,374 New	61,374 $1.64 Million
Q3 2018 Nov 15, 2018	SELL	$13.03 - $21.81 $139,355 - $233,257	-10,695 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$15.07 - $22.34 $161,173 - $238,926	10,695 New	10,695 $163,000
Q4 2017 Feb 15, 2018	SELL	$26.84 - $39.14 $247,384 - $360,753	-9,217 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $271,809 - $353,656	9,217	9,217 $347,000

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.18B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Acadia Pharmaceuticals Inc Transaction History